Skip to main content
SpringerLink
Log in

Epilepsy in Diffuse Low-Grade Gliomas

  • Chapter
  • First Online:
Book cover Diffuse Low-Grade Gliomas in Adults

Abstract

Epileptic seizures occur in the majority of patients with diffuse low-grade glioma (DLGG) as initial symptoms leading to tumor diagnosis. The temporal relationship between seizures and diagnosis in DLGG is, however, not always easily defined; minor focal seizures may go unnoticed for many years, seizures may occur first after radiological diagnosis in previously asymptomatic patients, and, in rare cases, seizures can precede the diagnosis of brain tumor. The risk of developing tumor-related seizures is inversely correlated with the growth rate of the tumor, being highest for patients with slowly growing tumors. The specific location of the tumor and its proximity to the cortex are other important factors affecting seizure risk in patients with DLGG.

About half of all patients with DLGG continue to have seizures before operation, in spite of adequate antiepileptic drug treatment. Poor seizure control has a strong negative impact on the health-related quality of life in this patient group. Improved seizure control in patients with medically refractory epilepsy can be achieved by tumor resection including removal of seizure foci, either as single treatment or in combination with radiotherapy and chemotherapy. When studying the relationship between seizure control and clinical outcome of DLGG, the natural evolution of these tumors has to be considered. The presence of seizures as initial and exclusive symptom at diagnosis is a strong favorable prognostic factor. There is some evidence that preoperative seizure freedom in DLGG is an additional prognostic factor for longer survival. Recurrent seizures after an initial seizure-free period or late-onset seizures are frequently associated with malignant progression, but the exact temporal relationship between seizures and tumor progression in DLGG remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aronica E, Gorter JA, van Vliet EA, Spliet WG, van Veelen CW, van Rijen PC, et al. Overexpression of the human major vault protein in gangliogliomas. Epilepsia. 2003;44:1166–74.

    Article  PubMed  CAS  Google Scholar 

  2. Aronica E, Boer K, Becker A, Redeker S, Spliet WG, van Rijen PC, et al. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience. 2008;151:272–92.

    Article  PubMed  CAS  Google Scholar 

  3. Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien). 2000;142:1–15.

    Article  CAS  Google Scholar 

  4. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendations for a definition of acute symptomatic seizure. Epilepsia. 2010;51:671–5.

    Article  PubMed  Google Scholar 

  5. Berntsson SG, Malmer B, Bondy ML, Qu MQ, Smits A. Tumor-associated epilepsy and glioma; are there common genetic pathways? Acta Oncol. 2009;48:328–42.

    Article  Google Scholar 

  6. Blonski M, Taillandier L, Herbet G, Maldonado IL, Beauchesne P, Fabbro M, et al. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol. 2012;106:353–66.

    Article  PubMed  CAS  Google Scholar 

  7. Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol. 2003;14:1715–21.

    Article  PubMed  CAS  Google Scholar 

  8. Brogna C, Gil Robles S, Duffau H. Brain tumors and epilepsy. Expert Rev Neurother. 2008;8:941–55.

    Article  PubMed  Google Scholar 

  9. Casazza M, Gilioli I. Non-convulsive status epilepticus in brain tumors. Neurol Sci. 2011;32 Suppl 2:237–9.

    Article  Google Scholar 

  10. Cavaliere R, Farace E, Schiff D. Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol. 2006;63:1746–9.

    Article  PubMed  Google Scholar 

  11. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108:227–35.

    Article  PubMed  Google Scholar 

  12. Chen X, Dai J, Jiang T. Supratentorial WHO grade II glioma invasion: a morphologic study using sequential conventional MRI. Br J Neurosurg. 2010;24:196–201.

    Article  PubMed  Google Scholar 

  13. Cibula JE, Gilmore RL. Secondary epileptogenesis in humans. J Clin Neurophysiol. 1997;14:111–27.

    Article  PubMed  CAS  Google Scholar 

  14. Conti L, Palma E, Roseti C, Lauro C, Cipriani R, de Groot M, et al. Anomalous levels of Cl− transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia. 2011;52:1635–44.

    Article  PubMed  CAS  Google Scholar 

  15. Danfors T, Ribom D, Berntsson SG, Smits A. Epileptic seizures and survival in early disease of grade 2 gliomas. Eur J Neurol. 2009;16:823–31.

    Article  PubMed  CAS  Google Scholar 

  16. Devinsky O. Patients with refractory seizures. N Engl J Med. 1999;340:1565–70.

    Article  PubMed  CAS  Google Scholar 

  17. Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer. 2004;100:2622–6.

    Article  PubMed  Google Scholar 

  18. Engel Jr J, Van Ness PC, Rasmussen TB. Outcome with respect to epileptic seizures. In: Engel Jr J, editor. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press Ltd; 1993. p. 609–21.

    Google Scholar 

  19. Fassunke J, Majores M, Tresch A, Niehusmann P, Grote A, Schoch S, et al. Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors. Brain. 2008;131:3034–50.

    Article  PubMed  Google Scholar 

  20. Fritschy JM. Epilepsy, E/I balance and GABA(A) receptor plasticity. Front Mol Neurosci. 2008;1:5.

    Article  PubMed  Google Scholar 

  21. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886–93.

    Article  PubMed  CAS  Google Scholar 

  22. Hildebrand J, Lecaille C, Perennes J, Delattre JY. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65:212–5.

    Article  PubMed  Google Scholar 

  23. International League Against Epilepsy (ILAE). Commission on Epidemiology and Prognosis, International League Against Epilepsy Guidelines on epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–6.

    Article  Google Scholar 

  24. Jaeckle KA, Ballman K, Furth A, Buckner JC. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology. 2009;13(73):1207–13.

    Article  Google Scholar 

  25. Jobst BC, Siegel AM, Thadani VM, Roberts DW, Rhodes HC, Williamson PD. Intractable seizures of frontal lobe origin: clinical characteristics, localizing signs, and results of surgery. Epilepsia. 2000;41:1139–52.

    Article  PubMed  CAS  Google Scholar 

  26. Kaloshi G, Psimaras D, Mokhtari K, Dehais C, Houillier C, Marie Y, et al. Supratentorial low-grade gliomas in older patients. Neurology. 2009;73:2093–8.

    Article  PubMed  CAS  Google Scholar 

  27. Khan T, Akthar W, Wotton CJ, Hart Y, Turner MT, Goldacre MJ. Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study. J Neurol Neurosurg Psychiatry. 2011;82:1041–5.

    Article  PubMed  Google Scholar 

  28. King MA, Newton MR, Jackson GD, Fitt GJ, Mitchell LA, Silvapulle MJ, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet. 1998;352:1007–11.

    Article  PubMed  CAS  Google Scholar 

  29. Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360:1361–8.

    Article  PubMed  CAS  Google Scholar 

  30. Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54:514–20.

    Article  PubMed  Google Scholar 

  31. Kurzwelly D, Herrlinger U, Simon M. Seizures in patients with low-grade gliomas-incidence, pathogenesis, surgical management, and pharmacotherapy. Adv Tech Stand Neurosurg. 2010;35:81–111.

    Article  PubMed  CAS  Google Scholar 

  32. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–9.

    Article  PubMed  CAS  Google Scholar 

  33. Lombardi D, Marsh R, de Tribolet N. Low grade glioma in intractable epilepsy: lesionectomy versus epilepsy surgery. Acta Neurochir Suppl. 1997;68:70–4.

    PubMed  CAS  Google Scholar 

  34. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol. 2003;53:524–8.

    Article  PubMed  Google Scholar 

  35. Mandonnet E, Pallud J, Fontaine D, Taillandier L, Bauchet L, Peruzzi P, et al. Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev. 2010;33:91–6.

    Article  PubMed  Google Scholar 

  36. Manford M, Fish DR, Shorvon SD. An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Brain. 1996;119:17–40.

    Article  PubMed  Google Scholar 

  37. Mirsattari SM, Chong JJ, Hammond RR, Megyesi JF, Macdonald DR, Lee DH, Cairncross JG. Do epileptic seizures predict outcome in patients with oligodendroglioma? Epilepsy Res. 2011;94:39–44.

    Article  PubMed  Google Scholar 

  38. Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67:931–40.

    Article  PubMed  Google Scholar 

  39. Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003;14:1722–6.

    Article  PubMed  CAS  Google Scholar 

  40. Pallud J, Mandonnett E. Quantitative approach of the natural course of diffuse low-grade gliomas. In: Hayat MA, editor. Tumors of the central nervous system, vol. 2. Dordrecht/New York: Springer AB; 2011. p. 163–72.

    Chapter  Google Scholar 

  41. Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, et al. Natural history of incidental World Health Organization grade II gliomas. Ann Neurol. 2010;68:727–33.

    Article  PubMed  Google Scholar 

  42. Pallud J, Mandonnet E, Deroulers C, Fontaine D, Badoual M, Capelle L, Club de Neuro-Oncologie de la Société Française de Neurochirurgie (SFNC); Association des Neuro-Oncologues d’Expression Française (ANOCEF), et al. Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol. 2010;67:398–404.

    PubMed  Google Scholar 

  43. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group; European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076–84.

    Article  PubMed  Google Scholar 

  44. Prayson RA. Brain tumors arising in the setting of chronic epilepsy. In: Hayat MA, editor. Tumors of the central nervous system, vol. 2. Dordrecht/New York: Springer AB; 2011. p. 407–16.

    Chapter  Google Scholar 

  45. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E, et al. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol. 2007;61:484–90.

    Article  PubMed  CAS  Google Scholar 

  46. Rudà R, Trevisan E, Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol. 2010;22:611–20.

    Article  PubMed  Google Scholar 

  47. Schaller B, Rüegg SJ. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia. 2003;44:1223–32.

    Article  PubMed  Google Scholar 

  48. Shamji MF, Fric-Shamji EC, Benoit BG. Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev. 2009;32:275–84.

    Article  PubMed  Google Scholar 

  49. Sherman JH, Moldovan K, Yeoh HK, Starke RM, Pouratian N, Shaffrey ME, et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg. 2011;114:1617–21.

    Article  PubMed  Google Scholar 

  50. Shorvon S, Tomson T. Sudden unexpected death in epilepsy. Lancet. 2010;378:2028–38.

    Article  Google Scholar 

  51. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26:1338–45.

    Article  PubMed  Google Scholar 

  52. Smits A, Duffau H. Seizures and the natural history of World Health Organization grade II gliomas: a review. Neurosurgery. 2011;68:1326–33.

    PubMed  Google Scholar 

  53. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, et al. European Federation of Neurological Societies. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol. 2010;17:1124–33.

    Article  PubMed  CAS  Google Scholar 

  54. Swisher CB, Doreswamy M, Gingrich KJ, Vredenburgh JJ, Kolls BJ. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit Care. 2011;16(1):109–13.

    Article  Google Scholar 

  55. Taillandier L, Duffau H. Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases. Neurosurg Focus. 2009;27:E8.

    Article  PubMed  Google Scholar 

  56. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159–68.

    Article  PubMed  Google Scholar 

  57. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421–30.

    Article  PubMed  Google Scholar 

  58. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366:985–90.

    Article  PubMed  Google Scholar 

  59. Weller M, Gorlia T, Cairncross JG, van den Bent MJ, Mason W, Belanger K, et al. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology. 2011;77:1156–64.

    Article  PubMed  CAS  Google Scholar 

  60. Wen PY, Marks PW. Medical management of patients with brain tumors. Curr Opin Oncol. 2002;14:299–307.

    Article  PubMed  Google Scholar 

  61. Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42:282–6.

    Article  PubMed  CAS  Google Scholar 

  62. You G, Huang L, Yang P, Zhang W, Yan W, Wang Y, et al. Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas. Eur J Neurol. 2011;19(2):298–306.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Neurology Uppsala University, 751 85, Uppsala, Sweden

    Anja Smits MD, PhD

Authors
  1. Anja Smits MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anja Smits MD, PhD .

Editor information

Editors and Affiliations

  1. , INSERM U1051, Institute for Neurosciences of Montpelli, av. Augustin Fliche 80, Montpellier, 34295, France

    Hugues Duffau

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Smits, A. (2013). Epilepsy in Diffuse Low-Grade Gliomas. In: Duffau, H. (eds) Diffuse Low-Grade Gliomas in Adults. Springer, London. https://doi.org/10.1007/978-1-4471-2213-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2213-5_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2212-8

  • Online ISBN: 978-1-4471-2213-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation